Search results
Results from the WOW.Com Content Network
For the trial, the 14 participants underwent a surgical procedure in which a drug called EDIT-101 that encodes the CRISPR gene-editing components was injected under the retina of one of their eyes.
For the first time in history, a life has been saved by gene editing. After all conventional treatments failed to provide positive results, 1-year-old Layla and her family believed the girl would ...
With the discovery of various types of immune-related disorders, there is a need for diversification in prevention and treatment. Developments in the field of gene therapy are being studied to be included in the scope of this treatment, but of course more research is needed to increase the positive results and minimize the negative effects of gene therapy applications. [27]
Many of the most innovative treatments for oral herpes, however, are still in the early stages and being tested on animals. One novel approach, says Leib, is gene therapy to essentially edit out ...
Exagamglogene autotemcel is the first cell-based gene therapy treatment utilizing CRISPR/Cas9 gene editing technology to be approved by the US Food and Drug Administration (FDA). [13] The most common side effects include low levels of platelets and white blood cells, mouth sores, nausea, musculoskeletal pain, abdominal pain, vomiting, febrile ...
In the first study published regarding human germline engineering, the researchers attempted to edit the HBB gene which codes for the human β-globin protein. HBB mutations produce β-thalassaemia, which can be fatal. [7] Genome editing in patients who have these HBB mutations would leave copies of the unmutated gene, effectively curing the ...
NTLA-2002 is a wholly owned investigational in vivo CRISPR-based gene editing therapy in development as a single-dose treatment for this potentially life-threatening disease. Patient screening is active following Intellia’s successful end-of-Phase 2 meeting and submission of an Investigational New Drug Application amendment to the U.S. Food ...
In company studies, the treatment was considered safe, and it had a “highly positive benefit-risk for patients with severe sickle cell disease,” Dr. Stephanie Krogmeier, vice president for ...